Trials / Completed
CompletedNCT02108535
Comparative Analysis of Cost-effectiveness of Silver Dressing in Burns
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- University of Sorocaba · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The evidence is insufficient to determine whether the types of dressings containing silver differ in time / proportion for complete wound healing and pain. We will analyze the cost-effectiveness of these dressings in outpatients, considering the service provided by the Brazilian National Public Health System.
Detailed description
Randomized, single-center, single-blinded, controlled clinical trial. Adult patients (age between 18 and 65 years), regardless of sex, with second degree burns treated in outpatient regimen will be randomized (1:1) into two groups: 1% silver sulfadiazine and nanocrystalline silver. Primary outcome: \- Proportion of lesions completely epithelialized within 15 days. Secondary outcomes: * Time in days for complete epithelialization of the burned areas; * Number of dressing changes; * Level of pain associated with the application and removal of the dressings; * Direct medical and non-medical costs; * Need for surgery; * Incidence of infection; * Presence of local adverse reactions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nanocrystalline silver | Flexible polyester low-grip coated nano-crystalline silver layer. The level of silver is 1.64 mg/ cm². This dressing enables the sustained release of silver in humid conditions dynamically and reached a higher plateau than 60 mg / L in less than 2 hours, and maintains a uniform level by 72 hours. |
| DRUG | Silver Sulfadiazine | This is at Standard treatment. The cream silver sulphadiazine at 1% was applied on the burn aseptically in a thick layer, approximately 3 to 5 mm, ie 5 g per 80 cm2 |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2014-08-01
- Completion
- 2014-10-01
- First posted
- 2014-04-09
- Last updated
- 2021-05-18
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02108535. Inclusion in this directory is not an endorsement.